Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/EJE-09-0261
European Journal of Endocrinology, Vol 161, Issue 4, 647-651
Copyright © 2009 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
EJE-09-0261v1
161/4/647    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Saito, T.
Right arrow Articles by Fujita, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saito, T.
Right arrow Articles by Fujita, T.

CASE REPORT

Familial hypophosphatemic rickets caused by a large deletion in PHEX gene

Tasuku Saito1, Yutaka Nishii3, Toshiyuki Yasuda4, Nobuaki Ito2, Hisanori Suzuki2, Takashi Igarashi1, Seiji Fukumoto2 and Toshiro Fujita2

1 Division of Pediatrics2 Division of Nephrology and Endocrinology, Department of Medicine, University of Tokyo Hospital, Tokyo 113-8655, Japan3 Division of Nephrology and Endocrinology, Department of Medicine, Nagano Municipal Hospital, Nagano, 381-8551, Japan4 Division of Pediatrics, National Hospital Organization Chiba Medical Center, Chiba, 260-0042, Japan

(Correspondence should be addressed to S Fukumoto; Email: fukumoto-tky{at}umin.ac.jp)

Abstract

Context: X-linked hypophosphatemic rickets/osteomalacia (XLH), autosomal dominant and recessive hypophosphatemic rickets/osteomalacia (ADHR and ARHR) share common clinical features including high fibroblast growth factor 23 (FGF23) levels. These diseases are caused by mutations in phosphate regulating endopeptidase homolog, X-linked (PHEX), FGF23, and dentin matrix acidic phosphoprotein 1 (DMP1) gene respectively. It remains unclear whether these diseases can be clinically discriminated.

Objective: To clarify the underlying mechanism of patients with hypophosphatemic rickets whose parents showed no physical findings suggesting rickets.

Design and patients: The proband is a 39-year-old woman. She and her 37-year-old brother show the same clinical features such as bowing of legs together with hypophosphatemia (sister: P 1.8 mg/dl, brother: P 1.6 mg/dl) and high FGF23 levels (sister: 542 pg/ml, brother: 96 pg/ml). Physical findings of their parents are normal and ARHR was suspected.

Results: Sequencing of all coding exons and exon–intron junctions of DMP1 and FGF23 genes showed no mutation. Subsequent analysis revealed that there is a deletion of 52 143 bp including exons 1–3 in PHEX gene in the brother. His sister was found to be a heterozygote for the same deletion indicating that they are suffering from XLH. The same deletion was detected in the mother. However, the amount of the wild-type allele was more and that of the mutant one was less in genomic DNA from the mother compared with those from the sister. Single nucleotide polymorphism (SNP) analysis indicated that the mother has three kinds of PHEX alleles suggesting a somatic mosaicism.

Conclusion: Careful genetic analysis is mandatory for correct differential diagnosis of hypophosphatemic rickets with high FGF23 levels.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 European Society of Endocrinology.